Raj Srirajaskanthan

1.5k citations
27 papers · 344 indexed · h-index 10

Raj Srirajaskanthan

23 papers receiving 337 citations

Peers

Raj Srirajaskanthan
Comparison fields: 5 of 46
  • Neurology 185
  • Oncology 260
  • Epidemiology 281
  • Gastroenterology 28
  • Endocrinology, Diabetes and Metabolism 29
Replace David Mathews with:
David Mathews United States
Elaine Soffer United States
B. Lembcke Germany
Suntje Sander‐Struckmeier United States
Frans J.C. Cuperus Netherlands
R Nilius Germany
Luigi Verre Italy
Mohannad Dugum United States
Xian-fa Wang China
Hiromi Imazeki Japan
Raj Srirajaskanthan relative to David Mathews United States David Mathews's profile →
Citations per field
00.5×9.3×
David Mathews · 1×
Citations per year

Countries citing papers authored by Raj Srirajaskanthan

Since Specialization
Citations

This map shows the geographic impact of Raj Srirajaskanthan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raj Srirajaskanthan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raj Srirajaskanthan more than expected).

Fields of papers citing papers by Raj Srirajaskanthan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raj Srirajaskanthan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raj Srirajaskanthan. The network helps show where Raj Srirajaskanthan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raj Srirajaskanthan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raj Srirajaskanthan Line = papers co-authored together Raj Srirajaskanthan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20240
4 20240
5 20240
6 20242
7 20231
8 20236
9 20226
10 20224
11 202217
12 20212
13 202010
14 201910
15 2018100
16 201824
17 20181
18 201841
19 20167
20 200726

About Raj Srirajaskanthan

Raj Srirajaskanthan is a scholar working on Neurology, Oncology and Epidemiology, having authored 27 papers that have together received 344 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (24 papers), Lung Cancer Research Studies (20 papers), Neuroblastoma Research and Treatments (13 papers), Pancreatic and Hepatic Oncology Research (11 papers), Gyrotron and Vacuum Electronics Research (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Pituitary Gland Disorders and Treatments (1 paper) and Biochemical effects in animals (1 paper). The work is most often cited by research in Neurology (185 citations), Oncology (260 citations) and Epidemiology (281 citations). Raj Srirajaskanthan has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include John Ramage, Ron Basuroy, Maia Sissons, Catherine Bouvier, Martin O. Weickert, Matthew H. Kulke, Wenjun Jiang, Douglas Fleming, Petros Perros and Richard R.P. Warner. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026